CVE-2026-12386

LOWCVSS 3.9/10EPSS 0.10%

Last modified

CVE-2026-12386 is a low-severity vulnerability rated 3.9/10 on the CVSS scale. Improper null termination vulnerability in TUBITAK BILGEM Software Technologies Research Institute Pardus Pen allows Overflow Buffers. This issue affects Pardus Pen: from <=4.1.5 before 4.2.1.. EPSS estimates a 0.10% chance of exploitation in the next 30 days.

Description

Improper null termination vulnerability in TUBITAK BILGEM Software Technologies Research Institute Pardus Pen allows Overflow Buffers. This issue affects Pardus Pen: from <=4.1.5 before 4.2.1.

Metrics

CVSS 3.1
3.9/10

CVSS:3.1/AV:L/AC:L/PR:L/UI:R/S:U/C:L/I:N/A:L

EPSS Probability
0.10%

0.9th percentile

Probability of exploitation in the next 30 days. Learn more

Weakness Enumeration

Affected Software

Source: CNA advisory (CVE.org). NVD analysis pending.

VendorProductVersions
TUBITAK BILGEM Software Technologies Research InstitutePardus Pen>= <=4.1.5, < 4.2.1

References

Timeline

Published
Last Modified
Status
Deferred

Frequently Asked Questions

What is CVE-2026-12386?
Improper null termination vulnerability in TUBITAK BILGEM Software Technologies Research Institute Pardus Pen allows Overflow Buffers. This issue affects Pardus Pen: from <=4.1.5 before 4.2.1.
How severe is CVE-2026-12386?
CVE-2026-12386 has a CVSS score of 3.9/10 (LOW severity). The EPSS model estimates a 0.10% probability of exploitation in the next 30 days.
How do I fix CVE-2026-12386?
Check the vendor references and advisories linked above for patched versions and mitigation guidance. You can also run a Strix scan to test if your systems are affected.

How Strix Helps

Related CVEs from 2026

Are you affected by CVE-2026-12386?

Run a free Strix scan to check your systems for this vulnerability.

Scan your code now

Source: NVD / NIST